Department of Neurology, The Second Affiliated Hospital of Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, China.
UCLA Stroke Center, University of California, Los Angeles, Los Angeles, CA, USA.
Eur Radiol. 2018 Aug;28(8):3413-3421. doi: 10.1007/s00330-018-5369-3. Epub 2018 Mar 13.
To investigate the value of multi-segment clot (MSC) sign on dynamic CT angiography (CTA) in predicting recanalisation and outcome after reperfusion therapy in acute ischaemic stroke (AIS) with large artery occlusion (LAO).
We retrospectively reviewed data of anterior circulation LAO patients from a prospectively collected database for consecutive AIS patients who underwent perfusion CT (CTP) before treatment. MSC sign was defined as the presence of multiple segments on dynamic CTA derived from CTP data. Good outcome was defined as modified Rankin score 0-3 at 90 days.
A total of 181 LAO patients were enrolled. MSC sign was present in 73 (40.3%) patients. When compared with patients without MSC sign, patients with MSC sign had a significantly higher rate of recanalisation (76.7% versus 56.5%, p = 0.005) and good outcome (67.1% versus 51.0%, p = 0.035). Multivariable logistic regression analyses showed that MSC sign was an independent predictor for both recanalisation (OR [95% CI] = 2.237 [1.069-4.681]; p = 0.033) and good outcome (OR [95% CI] = 2.715 [1.154-6.388]; p = 0.022) after adjustment.
The MSC sign is a good indicator for recanalisation and good outcome after reperfusion therapy in anterior circulation LAO patients.
• MSC sign was present in about 40% acute anterior circulation LAO patients. • MSC sign is a predictor for recanalisation after reperfusion treatment. • Patients with MSC sign have a better outcome.
探讨多节段血栓(MSC)征在预测急性缺血性卒中(AIS)大动脉闭塞(LAO)患者再灌注治疗后再通和结局的价值。
我们回顾性分析了从前瞻性连续 AIS 患者采集的数据库中,接受治疗前灌注 CT(CTP)的前循环 LAO 患者的数据。MSC 征定义为 CTP 数据衍生的动态 CTA 上存在多个节段。良好结局定义为 90 天时改良 Rankin 评分 0-3 分。
共纳入 181 例 LAO 患者。73 例(40.3%)患者存在 MSC 征。与无 MSC 征的患者相比,有 MSC 征的患者再通率显著更高(76.7%比 56.5%,p = 0.005),良好结局的比例也更高(67.1%比 51.0%,p = 0.035)。多变量逻辑回归分析显示,MSC 征是再通(OR [95%CI] = 2.237 [1.069-4.681];p = 0.033)和良好结局(OR [95%CI] = 2.715 [1.154-6.388];p = 0.022)的独立预测因素。
MSC 征是前循环 LAO 患者再灌注治疗后再通和良好结局的良好指标。
MSC 征在前循环 LAO 患者中约占 40%。
MSC 征是再灌注治疗后再通的预测因素。
有 MSC 征的患者结局更好。